Arthritis Australia welcomes proposals to reduce the cost of medicines
Arthritis Australia has welcomed proposals to decrease the cost of medicines and improve accessibility for people with arthritis. CEO Jonathan Smithers said “People with arthritis face very high out of pocket costs to manage their condition, and are increasingly struggling to access medical appointments when they need them. Any measures that save consumers cost and difficulty in accessing medicines need to be seriously considered. A saving of $180 a year will make a real difference for many people.”
Discover more...
-
Arthritis Australia, Chronic Pain Australia and Consumers Health Forum of Australia Joint Statement ABC 4 Corners “Pain Factory” episode
Tuesday 9 April 2024 Last night’s episode of ABC 4 Corners highlighted the many adverse events people living with chronic musculoskeletal pain have experienced when...
-
Arthritis Australia welcomes funding for kids with arthritis
Arthritis Australia has welcomed Australian Government funding announced in the federal budget for kids living with juvenile arthritis, including renewed funding for Arthritis Australia and...
-
Anticipated Shortage of Abatacept (Orencia®)
Bristol Myers Squibb (BMS), the manufacturer of abatacept (Orencia®), has recently announced an expected shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox:
